TENET HEALTHCARE CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TENET HEALTHCARE CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $4.81B | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | $4.57B | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | $4.56B | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | $4.55B | Feb 24, 2020 |
| FY2019 | Dec 31, 2018 | $4.62B | Feb 24, 2020 |
| FY2019 | Sep 30, 2018 | $4.49B | Feb 24, 2020 |
| FY2019 | Jun 30, 2018 | $4.51B | Feb 24, 2020 |
| FY2019 | Mar 31, 2018 | $4.70B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $4.98B | Feb 25, 2019 |
| FY2018 | Sep 30, 2017 | $4.59B | Feb 25, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.31B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $20.68B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $20.56B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $19.17B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $19.49B | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $4.92B | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $4.56B | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $3.65B | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $4.52B | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $4.81B | Feb 19, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2010 | Dec 31, 2010 | $1.12B | Feb 25, 2011 |
| FY2010 | Dec 31, 2009 | $181.00M | Feb 25, 2011 |
| FY2010 | Dec 31, 2008 | $25.00M | Feb 25, 2011 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.51B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $5.96B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $2.51B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $2.33B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $2.87B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.99B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $1.54B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.64B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.11B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $1.25B | Feb 25, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.54B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.05B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $2.37B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $1.08B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.57B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $3.41B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $1.23B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.05B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.20B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $558.00M | Feb 25, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.01B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $931.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $751.00M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $762.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $658.00M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $540.00M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $670.00M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $617.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $707.00M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $875.00M | Feb 25, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.68B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $28.94B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $28.31B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $27.16B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $27.58B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $27.11B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $23.37B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $22.43B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $23.39B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $24.70B | Feb 25, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.70B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $20.39B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $22.80B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $22.55B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $23.32B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $24.22B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $21.42B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $20.30B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $20.98B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $21.23B | Feb 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.22B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $4.17B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $1.61B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $1.14B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.03B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $28.00M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | ($417.00M) | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | ($119.00M) | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | ($147.00M) | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $417.00M | Feb 26, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.20B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $10.69B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $10.31B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $10.12B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $9.26B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $8.81B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $7.25B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $7.28B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $7.02B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $7.43B | Feb 26, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.42B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.01B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | ($192.00M) | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | ($803.00M) | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | ($1.21B) | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | ($2.13B) | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | ($2.51B) | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | ($2.24B) | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | ($2.39B) | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | ($1.74B) | Feb 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.88B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.02B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $1.23B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $858.00M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $2.36B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $2.45B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $262.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $411.00M | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $611.00M | Feb 25, 2019 |
| FY2018 | Dec 31, 2016 | $716.00M | Feb 25, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 33 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 3 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | (1) | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 32 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 3 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | (1) | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |